branebrutinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for branebrutinib, covering 2024-01-16 to 2024-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis [Phase 2]